Farma Industria Ticino realizza una filiera produttiva locale di etanolo donando 940 litri all’EOC 23 April 2020
Helsinn Therapeutics (U.S.), Inc. waives copay fees for cancer-treating drug VALCHLOR® (mechlorethamine) gel to ensure eligible patients have access to treatment during the COVID-19 crisis 20 April 2020
IBSA JOINS THE FIGHT AGAINST COVID-19: DONATION OF CHF 500,000 AND MEDICAL SUPPLIES TO HELP THE MOST AFFECTED AREAS 6 April 2020
PRESS RELEASE – Coronavirus: the commitment and dedication of Farma Industria Ticino associated companies 30 March 2020
New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas 14 February 2020
Augusto Mitidieri – Most Influential CEO Europe 2019 for Humancentric Driven Innovation 31 January 2020
Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award 31 January 2020
Linkedin